So far, immunolabeling for estrogen and progesterone receptors has only been reported in two simple tubulopapillary mammary carcinomas of male guinea pigs that displayed the detection of receptors in nearly all tumor cells [7]. This evidence concerns the gene PGR and neoplasm.